SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test
At DNA Labs UAE, we offer the SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test. This test is designed to diagnose individuals with congenital myasthenic syndrome type 20, a specific type of congenital myasthenic syndrome associated with the SLC5A7 gene.
Test Components
The SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test includes the following components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test, it is important to provide the following:
- Clinical History of Patient who is going for SLC5A7 Gene Myasthenic Syndrome, congenital, type 20, presynaptic NGS Genetic DNA Test
- A Genetic Counselling session to draw a pedigree chart of family members affected with SLC5A7 Gene Myasthenic Syndrome, congenital, type 20, presynaptic
Test Details
The SLC5A7 gene is associated with a specific type of congenital myasthenic syndrome, known as type 20. This condition is characterized by weakness and fatigue of the muscles due to a disruption in the communication between nerve cells and muscle cells (neuromuscular junction).
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of myasthenic syndrome, NGS testing can identify genetic mutations or variations in the SLC5A7 gene that may be responsible for the condition.
By performing NGS genetic testing on the SLC5A7 gene, healthcare professionals can accurately diagnose individuals with congenital myasthenic syndrome type 20. This information is crucial for proper management and treatment of the condition.
Test Name | SLC5A7 Gene Myasthenic syndrome congenital type 20 presynaptic Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC5A7 Gene Myasthenic syndrome, congenital, type 20, presynaptic NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC5A7 Gene Myasthenic syndrome, congenital, type 20, presynaptic |
Test Details |
The SLC5A7 gene is associated with a specific type of congenital myasthenic syndrome, known as type 20. This condition is characterized by weakness and fatigue of the muscles due to a disruption in the communication between nerve cells and muscle cells (neuromuscular junction). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of myasthenic syndrome, NGS testing can identify genetic mutations or variations in the SLC5A7 gene that may be responsible for the condition. By performing NGS genetic testing on the SLC5A7 gene, healthcare professionals can accurately diagnose individuals with congenital myasthenic syndrome type 20. This information is crucial for proper management and treatment of the condition. |